Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple splicing variants of cdc25B regulate G2/M progression.

A R Forrest1, A K McCormack, C P DeSouza

  • 1Joint Oncology Program, Queensland Institute of Medical Research, Queensland, Brisbane, 4029, Australia.

Biochemical and Biophysical Research Communications
|July 15, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.

Genetics in medicine : official journal of the American College of Medical Genetics·2021
Same author

Intergenic disease-associated regions are abundant in novel transcripts.

Genome biology·2017
Same author

Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation.

Oncogene·2017
Same author

In vivo overexpression of Emi1 promotes chromosome instability and tumorigenesis.

Oncogene·2016
Same author

Survival outcomes in patients with multiple primary melanomas.

Journal of the European Academy of Dermatology and Venereology : JEADV·2015
Same author

A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.

Clinical genetics·2014

Alternate splicing creates multiple cdc25B variants, with cdc25B2 and cdc25B3 proteins regulating G2/M progression. Both variants are crucial for cell cycle control, as demonstrated by G2 arrest upon overexpression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • Mitotic progression relies on cyclin/CDK complexes, activated by cdc25B and cdc25C phosphatases.
  • Alternate splicing is a key mechanism generating protein diversity from single genes.

Purpose of the Study:

  • To investigate the role of different cdc25B variants in cell cycle regulation.
  • To determine the expression patterns and functional significance of cdc25B splice variants.

Main Methods:

  • Analysis of cdc25B alternate splicing and protein expression across various cell lines.
  • Functional studies involving overexpression of catalytically inactive cdc25B variants.

Main Results:

  • At least five cdc25B variants arise from alternate splicing, with cdc25B2 and cdc25B3 being the only detectable protein forms.

Related Experiment Videos

  • cdc25B2 shows lower expression than cdc25B3, with both increasing significantly during G2 and mitosis.
  • Overexpression of inactive cdc25B2 or cdc25B3 induced a G2 cell cycle arrest.

    • Conclusions:

    • Both cdc25B2 and cdc25B3 proteins play critical roles in regulating the G2/M phase transition.
    • Alternate splicing of cdc25B generates functionally distinct variants that are essential for cell cycle progression.